List view / Grid view
News from the Pasteur Institute in France reports on how multi organisational efforts of numerous research institutes enabled the scientific community to gain key insight into the Omicron variant, facilitating a rapid life-saving response.
Taking a novel approach to antibiotic discovery, researchers at Rockefeller University have hit upon a promising solution to the problem of superbugs – a pervasive threat in hospitals the world over.
Despite the rapid deployment of vaccines among global populations, therapeutics such as antibodies are still required. Here, Dr Steve Carroll, Vice President of Pre-clinical Sciences at IGM Biosciences, explains how a potential Immunoglobulin M (IgM) antibody treatment has been developed that shows promise for combatting SARS-CoV-2 and variants of concern in pre‑clinical…
A new study has used a combination of imaging methods to understand how the Piezo protein works, improving research into treatments for conditions such as high blood pressure.
A research team has developed a method for regenerating old brain stem cells from rat models, which could be used to treat age-related brain diseases.
A new technique called ‘ubiquitin clipping’ has been created which could aid proteomics research and the development of new drugs for ubiquitination.
Researchers have successfully used a no-cut CRISPR gene editing technique as a therapy for muscular dystrophy in mice models.
Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.
A study has discovered that the damage of projection neurons in the brain is caused by immune cells, leading to MS.
A new study has identified a class of immune cells that respond to tuberculosis, indicating a drug target for the condition.
Researchers have presented their new technology for accurately inserting genes into the genome without cutting DNA.
Researchers have found that certain immune cells aid in fighting tuberculosis bacteria, providing a new drug target.
Researchers have grown identical brain organoids for the first time, opening avenues for neurological research.
A study has detailed the change in the gut microbiome, increasing the potential for new IBD therapies.
A study has shown that the organisation of the gut is broken into functional compartments, improving opportunities for gastrointestinal disorder drugs and oral vaccines.
